HAMBURG, Germany -- A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed. Meeting the ...

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Pregnant women with type 1 diabetes had a higher time in ...

Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Hybrid closed-loop insulin delivery was most ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

For pregnant women with type 1 diabetes, a technology giving insulin doses as informed by a smartphone algorithm, helps them better manage their blood sugars, compared to traditional insulin pumps or ...

Experts urged that hybrid closed-loop technology be offered to all pregnant women with type 1 diabetes as research showed it improved maternal glucose levels during pregnancy complicated by type 1 ...

Closed-loop insulin delivery systems, designed to automate aspects of diabetes management in children and teenagers, yielded significantly higher blood glucose time in range for children with type 1 ...

Diabetes management startup Tidepool has just locked in a $6 million grant from the Leona M. and Harry B. Helmsley Charitable Trust and JDRF in order to kick off develop an app for hybrid closed-loop ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...

Results from the AiDAPT trial show hybrid closed-loop therapy significantly improves maternal glycemic control during pregnancy complicated by T1D. Hybrid closed-loop insulin therapy significantly ...